Aris’ main interests are in Health Technology Assessment (HTA) with a focus on multi-disciplinary methodological and applied health services research for health care evaluation using health economics and decision analysis. He will be leading the development of a research programme for assessing the value of new oncology products at an early stage using decision analytic modeling techniques and will be collaborating with the Center for Health Policy & Outcomes at the Memorial Sloan Kettering Cancer Center. At LSE, most recently Aris has been involved with the EU funded project Impact-HTA, co-leading the research activities of a work package on multi-criteria value methods and working towards a new value framework for medicines in collaboration with different HTA bodies. He is also involved in a project initiative with the European Society for Medical Oncology (ESMO), co-leading research activities towards the development of an ESMO value framework for cancer medicines. In the past, Aris has undertaken contracted research, training and advisory work for the European Commission, the World Health Organization, national health ministries and various biopharmaceutical organisations.

Google Scholar page: https://scholar.google.co.uk/citations?user=YEcogaQAAAAJ&hl=en